Aurinia Pharmaceuticals Inc.
DE ˙ DB ˙ CA05156V1022
13,91 € ↑0,53 (3,96%)
2026-06-04
CENA AKCJI
SecurityDE:IKAP / Aurinia Pharmaceuticals Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership15,604 shares
Latest Disclosed Value $ 231,251
Citigroup Inc ownership in IKAP / Aurinia Pharmaceuticals Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 15,604 shares of Aurinia Pharmaceuticals Inc. (DE:IKAP) valued at $198,171 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 7,632 shares of Aurinia Pharmaceuticals Inc.. This represents a change in shares of 104.45% during the quarter. The current value of the position is $217,052 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (IKAP) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:IKAP / Aurinia Pharmaceuticals Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 15,604 7,972 104.45 231 90.91 0.0000
2026-02-13 2025-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 7,632 -9,938 -56.56 122 -37.63 0.0001
2025-11-10 2025-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 17,570 -33,791 -65.79 194 -55.40 0.0001
2025-08-11 2025-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 51,361 -52,813 -50.70 435 -48.03 0.0002
2025-05-12 2025-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 104,174 -558,458 -84.28 838 -85.93 0.0004
2025-02-12 2024-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 662,632 8,446 1.29 5,950 24.09 0.0035
2024-11-12 2024-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 654,186 -51,909 -7.35 4,795 18.95 0.0028
2024-08-12 2024-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 706,095 -53,174 -7.00 4,032 6.00 0.0026
2024-05-10 2024-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 759,269 -657,565 -46.41 3,804 -70.14 0.0025
2024-02-09 2023-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 1,416,834 532,884 60.28 12,737 85.45 0.0090
2023-12-06 2023-09-30 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 883,950 -20,956 -2.32 6,868 -21.59 0.0051
2023-11-09 2023-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 883,950 -20,956 6,868 0.0051
2023-08-10 2023-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 904,906 56,271 6.63 8,759 -5.83 0.0057
2023-05-11 2023-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 848,635 -1,068 -0.13 9,301 153.43 0.0065
2023-02-09 2022-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 849,703 -977 -0.11 3,671 -42.63 0.0029
2022-11-10 2022-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 850,680 -11,057 -1.28 6,397 -26.13 0.0046
2022-08-10 2022-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 861,737 95,323 12.44 8,660 -8.73 0.0064
2022-05-12 2022-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 766,414 -1,781 -0.23 9,488 -46.00 0.0058
2022-02-10 2021-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 768,195 758,272 7,641.56 17,569 7,885.91 0.0094
2021-11-10 2021-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 9,923 -4,447 -30.95 220 18.28 0.0001
2021-08-10 2021-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 14,370 11,935 490.14 186 481.25 0.0001
2021-05-13 2021-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 2,435 -1,374 -36.07 32 -39.62 0.0000
2021-02-11 2020-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 3,809 -6,683 -63.70 53 -65.58 0.0000
2020-11-12 2020-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 10,492 -9,763 -48.20 154 -53.05 0.0001
2020-08-12 2020-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 20,255 13,669 207.55 328 245.26 0.0003
2020-05-12 2020-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 6,586 -6,080 -48.00 95 -63.04 0.0001
2020-02-12 2019-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 12,666 8,447 200.21 257 1,017.39 0.0002
2019-11-08 2019-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 4,219 2,086 97.80 23 64.29 0.0000
2019-08-12 2019-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 2,133 879 70.10 14 75.00 0.0000
2019-05-13 2019-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 1,254 1,199 2,180.00 8 0.0000
2019-02-12 2018-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 55 3 5.77 0 0.0000
2018-11-13 2018-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 52 -2,948 -98.27 0 -100.00
2018-08-10 2018-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 3,000 -366 -10.87 17 -5.56 0.0000
2018-05-11 2018-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 3,366 -1,469 -30.38 18 -21.74 0.0000
2018-02-12 2017-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 4,835 1,835 61.17 23 21.05 0.0000
2017-11-13 2017-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 3,000 0 0.00 19 5.56 0.0000
2017-08-11 2017-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 3,000 -15,000 -83.33 18 -86.36 0.0000
2017-05-12 2017-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 18,000 18,000 132 0.0001
2016-05-13 2016-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 0 -6 -100.00 0 0.0000
2016-02-12 2015-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 6 6 0.00 0 0.0000
2015-08-13 2015-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 0 -40 -100.00 0 0.0000
2015-05-14 2015-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 40 -131 -76.61 0 -100.00
2015-02-17 2014-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 171 171 1 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-10 2025-09-30 13F AURINIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-11 2025-06-30 13F AURINIA PHARMACEUTICALS COM Call 50,000 424 n/a n/a n/a
2025-05-12 2025-03-31 13F AURINIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-12 2024-12-31 13F AURINIA PHARMACEUTICALS COM Call 50,000 150.00 449 207.53 n/a n/a n/a
2024-11-12 2024-09-30 13F AURINIA PHARMACEUTICALS COM Call 20,000 -59.92 147 -48.59 n/a n/a n/a
2024-08-12 2024-06-30 13F AURINIA PHARMACEUTICALS COM Call 49,900 0.00 285 14.06 n/a n/a n/a
2024-05-10 2024-03-31 13F AURINIA PHARMACEUTICALS COM Call 49,900 250 n/a n/a n/a
2024-02-09 2023-12-31 13F AURINIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-12-06 2023-09-30 13F/A AURINIA PHARMACEUTICALS COM Call 40,000 -19.84 311 -35.82 n/a n/a n/a
2023-11-09 2023-09-30 13F AURINIA PHARMACEUTICALS COM Call 40,000 311 n/a n/a n/a
2023-08-10 2023-06-30 13F AURINIA PHARMACEUTICALS COM Call 49,900 483 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-10 2025-09-30 13F AURINIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-11 2025-06-30 13F AURINIA PHARMACEUTICALS COM Put 50,000 424 n/a n/a n/a
2025-05-12 2025-03-31 13F AURINIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-12 2024-12-31 13F AURINIA PHARMACEUTICALS COM Put 50,000 150.00 449 207.53 n/a n/a n/a
2024-11-12 2024-09-30 13F AURINIA PHARMACEUTICALS COM Put 20,000 -59.92 147 -48.59 n/a n/a n/a
2024-08-12 2024-06-30 13F AURINIA PHARMACEUTICALS COM Put 49,900 0.00 285 14.06 n/a n/a n/a
2024-05-10 2024-03-31 13F AURINIA PHARMACEUTICALS COM Put 49,900 250 n/a n/a n/a
2024-02-09 2023-12-31 13F AURINIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-12-06 2023-09-30 13F/A AURINIA PHARMACEUTICALS COM Put 40,000 -19.84 311 -35.82 n/a n/a n/a
2023-11-09 2023-09-30 13F AURINIA PHARMACEUTICALS COM Put 40,000 311 n/a n/a n/a
2023-08-10 2023-06-30 13F AURINIA PHARMACEUTICALS COM Put 49,900 483 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.